[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ehealth\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ehealth":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,45,72,110,135,162,187,217],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100642004","the-enhance-project-toolkit-100642004",false,"NCT07649278","The ENHANCE Project Toolkit","Mobile Health Strategies to Support Longitudinal Engagement in Comprehensive, Community-based Prevention Services for People Who Use Drugs (Aim 3)","Inclusion Criteria (Pilot Participant):\n\n* Be at least 18 years old\n* Be able to read and write in English\n* Report drug use in the past 30 days, defined as\n\n  * Any use of illicit stimulants, opioids, OR\n  * Use of prescription opioids by a route other than \"by mouth\u002Fswallowed\"\n* Additionally report recent drug use of at least twice in the past 7 days\n* Have NOT used any of the following harm reduction services in the past 6 months:\n\n  * In-person community-based prevention services for people who use drugs\n  * Overdose crisis hotlines\n  * Online mail-order prevention supply delivery\n  * Apps for supporting addiction treatment or recovery\n\nInclusion Criteria (Peer Mentor Participant):\n\n* Be at least 18 years old\n* Be able to read and write in English\n* Have served as a member of the existing Community Leadership Team.\n\nExclusion Criteria:\n\n* Are under the age of 18\n* Have impaired decision making capacity at the time of screening\n* Do not have the ability to participate in screening and enrollment activities in any one of the following ways:\n\n  * Traveling to their nearest participating Vivent Health health center\n  * Coordinating a visit with the Vivent Health harm reduction mobile unit\n  * Accessing and completing the online screening survey on a personal wifi\u002Finternet enabled device","ALL","18 Years",{"count":19,"type":20},40,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study will examine the feasibility, appropriateness, and acceptability of a bundle of smartphone-based tools for lowering overdose risk. 40 participants will be enrolled and can expect to be on study for up to 9 months.",[26,27,28],"Substance Related Disorder","Drug Overdose","eHealth",[30,31],"Substance Use Disorder","Opioid Use Disorder","NOT_YET_RECRUITING","2026-06-10",{"date":35,"type":36},"2026-06-16","ACTUAL",{"date":38,"type":20},"2026-06",{"date":40,"type":20},"2027-06",{"name":42,"class":43},"University of Wisconsin, Madison","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":52,"sex":53,"minAge":17,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":21,"phases":56,"briefSummary":58,"conditions":59,"keywords":4,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":71},"100481288","phase-4-integrated-e-health-electronic-health-for-hiv-and-substance-use-disorders-in-justice-involved-women-100481288","NCT05547048","Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women","Integrated eHealth for HIV and Substance Use Disorders in Justice Involved Women","Inclusion Criteria:\n\n* woman\n* have access to a working mobile or landline phone\n* Lifetime CJ-involvement (probation, parole, intensive pretrial or community supervision, or release from prison\u002Fjail)\n* are confirmed HIV-negative by point-of-care 3rd generation HIV antibody test\n* meet clinical criteria for PrEP\n* have opioid use disorder (regardless of baseline treatment status)\n\nExclusion Criteria:\n\n* unable or unwilling to provide informed consent\n* pregnant or breast-feeding\n* currently taking PrEP at the time of study enrollment\n* not comfortable conversing in English or Spanish.",true,"FEMALE",{"count":55,"type":20},250,[57],"PHASE4","The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ).\n\nThis study evaluates a newly validated PrEP decision aid and eHealth for integrated PrEP and MOUD compared to a decision aid-only for WICJ with OUD.",[60,31,28],"HIV","RECRUITING","2026-06-01",{"date":64,"type":36},"2026-06-03",{"date":66,"type":36},"2023-07-25",{"date":68,"type":20},"2027-04-01",{"name":70,"class":43},"Yale University",2,{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":80,"enrollmentInfo":81,"targetDuration":4,"studyType":21,"phases":83,"briefSummary":84,"conditions":85,"keywords":97,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":44},"100531998","the-fit-with-us-study-100531998","NCT06207084","The Fit With Us Study","Precision-based Teleexercise Trial to Increase Adherence in People With Disabilities","FITWITHUS","Eligible participants must meet the following criteria to be included: (1) live with a permanent physical disability that limits their mobility; (2) be 18 to 89 years of age; (3) have broadband internet access; (4) be able to speak and read English; and (5) be able to attend coaching and training sessions during the weekdays.\n\nParticipants are excluded from participation if they (1) possess significant visual acuity that prevents seeing a computer screen to follow a home exercise program; (2) have been regularly engaging in exercise for the previous 3 months; (3) are unable to use their arms and their legs at all to exercise; (4) are unsafe to exercise; (5) self-report that they are currently pregnant","89 Years",{"count":82,"type":20},257,[23],"The purpose of this 32-week study is to use an innovative experimental design known as SMART (Sequential Multiple Assignment Randomized Trial), which will allow us to determine the best way to sequence the delivery of teleexercise (referred to as an adaptive intervention), combined with predictive analytics on participant adherence in a stepped program of physical activity interventions. All 257 participants will have access to a library of recorded video exercise content, and a weekly wellness article. Some participants will receive health coaching calls (1st randomization). Analytic data will be used to determine which participants are responding or not responding to the intervention. Participants not responding after 4 weeks will receive either live one-on-one or group exercise training (2nd randomization). After 8 weeks, the participant will receive only pre-recorded exercise content and articles for a 24-week maintenance phase (weeks 9-32). The study outcomes are: The effectiveness of the adaptive interventions; Exploring mediating and moderating variables; Sensitivity analysis of the predictive analytics.",[86,87,88,89,90,91,28,92,93,94,95,96],"Mobility Limitations","Disability Physical","Telehealth","Health Coaching","Physical Activity","Behavior, Health","Health Literacy","Self Efficacy","Fatigue","Usability","Predictive Model",[98,99,100],"telehealth","health coaching","disability","2026-01-07",{"date":103,"type":36},"2026-01-09",{"date":105,"type":36},"2024-09-01",{"date":107,"type":20},"2029-02-01",{"name":109,"class":43},"University of Alabama at Birmingham",{"id":111,"slug":112,"hasResults":11,"nctId":113,"briefTitle":114,"officialTitle":115,"acronym":43,"eligibilityCriteria":116,"healthyVolunteers":11,"sex":16,"minAge":117,"maxAge":4,"enrollmentInfo":118,"targetDuration":4,"studyType":21,"phases":120,"briefSummary":121,"conditions":122,"keywords":4,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":134},"100504968","effect-of-occupational-therapy-at-home-e-rehabilitation-other-for-persons-post-stroke-100504968","NCT05855226","Effect of Occupational Therapy at Home E-Rehabilitation (OTHER) for Persons Post-stroke","Supporting Daily Functioning of Persons With a Neurological Disorder: (Cost)Effectiveness of Occupational Therapy at Home E-Rehabilitation (OTHER) for Persons Post-stroke","Inclusion Criteria:\n\n* be able to walk a few steps with or without a walking device.\n* 60 years or older\n* an assessment score of at least 16 on the Montreal Cognitive Assessment (MoCA)\n* an indication for follow up GR at home\n\nExclusion Criteria:\n\n* Who are terminally ill\n* Who have severe aphasia; problems with understanding.\n* Who has been assessed legally incapable by a geriatric doctor","60 Years",{"count":119,"type":20},171,[23],"The goal of this (cost)effectiveness study is to compare care as usual with OTHER-intervention in Cerebro Vascular Accident (CVA) older adults in Geriatric Rehabilitation (GR). The main question\\[s\\] it aims to answer are:\n\n1. What is the effectiveness of OTHER, as compared to occupational therapy as usual (CAU), on improving the self-perceived performance in daily activities of community-dwelling older persons post-stroke over a 24-week period after initiation of OTHER or CAU, as measured longitudinally (at week 4, 13 and 26)?\n\n   Secondary:\n2. What is the effectiveness of OTHER on improving satisfaction with the perceived daily performance of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)\n3. What is the effectiveness of OTHER on improving physical activity of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)\n4. What is the effectiveness of OTHER on improving self-management of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)\n5. How do persons post-stroke and OT's experience and how do they reflect on OTHER in supporting a sense of self-management, safety and improving daily functioning? (qualitative approach).\n6. What factors influenced the intervention delivery and the perceived benefits in the OTHER study (process evaluation)? 1) monitoring treatment fidelity, barriers and facilitators for implementation; 2) gain insight into the impact of OTHER on the GR transition to home; 3) to gain insight into what stroke survivors and OT's think of OTHER. 4) how participants, and professionals experience and thoughts they have on the OTHER-intervention in supporting daily functioning and self-management\n\n   Cost-effectiveness\n7. What is the cost-effectiveness of OTHER on improving self-perceived performance in daily activities and Quality Adjusted Life Years (QALYs) of community-dwelling persons post-stroke, 26 weeks after start compared to usual OT? (quantitative approach)\n\nParticipants will get the OTHER-intervention treatment given by de occupational therapist which consists of activity monitoring, coaching and videoconferencing to optimalise the transition from clinical care to home.\n\nResearchers will compare care as usual to see if there is a effect on improving the self-perceived performance in daily activities, self-management and improving physical activity .",[123,28,124],"Stroke","Occupational Therapy","2025-09-04",{"date":127,"type":36},"2025-09-10",{"date":129,"type":36},"2023-03-13",{"date":131,"type":20},"2026-01",{"name":133,"class":43},"Amsterdam University of Applied Sciences",9,{"id":136,"slug":137,"hasResults":11,"nctId":138,"briefTitle":139,"officialTitle":140,"acronym":141,"eligibilityCriteria":142,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":143,"enrollmentInfo":144,"targetDuration":4,"studyType":21,"phases":146,"briefSummary":147,"conditions":148,"keywords":4,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":160,"locationsCount":44},"100480266","evaluating-the-effectiveness-of-the-gill-ehealth-intervention-to-improve-physical-health-and-lifestyle-behaviours-in-patients-with-severe-mental-illness-100480266","NCT05533749","Evaluating the Effectiveness of the GILL eHealth Intervention to Improve Physical Health and Lifestyle Behaviours in Patients With Severe Mental Illness","Improving Physical Health and Lifestyle Behaviors in Patients With Serious Mental Illness: a Cluster Randomized Controlled Trial on the Effectiveness of the Nurse-led GILL eHealth Intervention","GILL","Inclusion Criteria:\n\n* Meet the criteria of severe mental illness\n* Aged from 18 to 65 years\n* Body mass index (BMI) ≥ 27\n* Access and ability to use internet\n* Able and willing to sign informed consent\n\nExclusion Criteria:\n\n* Contra-indications (to be assessed by the treating physician\u002Fpsychiatrist) for participation due to acute psychiatric crisis or severe somatic diseases\n* Subjects with a cognitive impairment sufficient to interfere with their ability to provide informed consent, complete study questionnaires, or participate in the intervention\n* Pregnant or breastfeeding women at the time of inclusion\n* Subject not able to communicate in the Dutch language","65 Years",{"count":145,"type":20},258,[23],"The aim of this study is to evaluate the effectiveness of the nurse-led GILL (Gezondheid in Lichaam en Leefstijl) eHealth intervention in patients with serious mental illness (SMI), compared to usual care. Expected is that the GILL eHealth intervention will be more effective than usual care in improving physical health and lifestyle behaviors. To evaluate this, we will perform a cluster randomized controlled trial with an embedded process evaluation of the implementation of the GILL intervention. 258 adult patients with serious mental illness and a body mass index of 27 or higher (overweight\u002Fobesity) will be included. The GILL eHealth intervention consists of two complementary modules for (a) somatic screening and (b) lifestyle promotion, resulting in a personalized somatic treatment and lifestyle plan. Trained mental health nurses and clinical nurse specialists will implement the intervention within the multidisciplinary treatment context, and will guide and support the patients in the promotion of their somatic health, including cardiometabolic risk management. The intervention will be compared to usual care, which includes treatment according to national guidelines. The outcome measures will be metabolic syndrome severity (primary), fitness, physical activity, lifestyle behaviors, quality of life, recovery, psychosocial functioning, health related self-efficacy and health care utilization after 1 year. The process evaluation focuses on the feasibility of the eHealth intervention, its acceptability for patients and health care providers (mainly mental health nurses and clinical nurse specialists), and barriers\u002Ffacilitators to implementation.",[149,150,151,152,28],"Severe Mental Disorder","Metabolic Syndrome","Lifestyle","Somatic Screening","2024-06-13",{"date":155,"type":36},"2024-06-14",{"date":157,"type":36},"2024-05-30",{"date":159,"type":20},"2025-12-31",{"name":161,"class":43},"Amsterdam UMC, location VUmc",{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":167,"acronym":4,"eligibilityCriteria":168,"healthyVolunteers":11,"sex":16,"minAge":169,"maxAge":170,"enrollmentInfo":171,"targetDuration":4,"studyType":21,"phases":173,"briefSummary":174,"conditions":175,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":178,"lastUpdatePostDateStruct":179,"startDateStruct":181,"completionDateStruct":183,"leadSponsor":185,"locationsCount":4},"100491710","luchtbrug-junior-the-next-step-100491710","NCT05682664","Luchtbrug Junior: the Next Step","Luchtbrug Junior: Online Monitoring for Young Children With Preschool Wheeze","Inclusion criteria\n\n* Children aged 2 to 6 years with a doctor's diagnosis of preschool wheeze\n* Children have an indication for regular follow-up of at least one year by a paediatrician because of respiratory symptoms;\n* Children are treated with inhaler medication, including inhaled corticosteroids;\n* A history of three episodes of wheezing managed by a healthcare professional of which at least one was observed by a paediatrician in the last 12 months prior to the study, or:\n* At least one hospital admissions due to pulmonary symptoms before inclusion.\n* Informed consent of parents\u002Fcaregivers\n\nExclusion criteria\n\n* Underlying chronic cardiopulmonary or neuromuscular condition, or known recurrent aspirations;\n* Underlying syndromes associated with pulmonary comorbidities;\n* Prematurity \\\u003C36 weeks after gestation;\n* Inability of parents\u002Fcaregivers\u002Fcaretakers to understand and\u002For read Dutch;\n* No access to a smartphone and\u002For internet.","2 Years","6 Years",{"count":172,"type":20},270,[23],"Rationale:\n\nThe introduction of e-health in the monitoring and management of patients with chronic conditions can be beneficial and efficient. The introduction of an online monitoring and management tool, \"Luchtbrug\", for children 6-16 yrs of age with asthma while reducing 50% of visits to the outpatient clinic, results in similar or improved asthma control while reducing costs. It is highly likely that this concept of e-health is suitable for other chronic conditions. Therefore the aim of the study is to investigate the added value of online monitoring and management of children with preschool wheeze (2-6 yrs of age).\n\nObjective: To assess whether the number of symptom free days can be improved using online monitoring and disease management via Luchtbrug Junior, while reducing the number of outpatient clinic visits by 50%\n\nStudy design: Prospective multicentre (n=6) randomised trial in which disease management via Luchtbrug Junior will be compared with usual care.\n\nFollow-up: 12 months.\n\nStudy population: children aged 2-6 yrs with preschool wheezing (multiple episode of cough, wheeze and dyspnoea).\n\nIntervention (if applicable): Children will be randomised into usual care (n=135) or partly online care via Luchtbrug Junior (n = 135)\n\nMain study parameters\u002Fendpoints:\n\nPrimary objective: Number of symptom free days (SFDs) based on the TRACK questionnaire, during the last four weeks of the study (measured at 12 months).\n\nSecondary objectives:\n\nHealthcare consumption: unscheduled visits Emergency Department (ED) or outpatient clinic, unscheduled phone calls, hospital admissions) Questionnaires into: Quality of Life (QoL), cost-effectiveness (direct and indirect costs), self-management of patients, adherence to treatment, satisfaction of parents\u002Fcaregivers.\n\nUsual care consists of regular visits to the outpatient clinic every 3 months after starting the study. In between visits contact with the healthcare team is by telephone as needed. At 3, 6, 9 and 12 months, patients will be asked to complete the TRACK questionnaire.\n\nOnline care using Luchtbrug Junior will include visits to the outpatient clinic every 6 months after starting the study. In between visits, parents\u002Fcaregivers of the patient will be asked to answer the digital version of TRACK questionnaire monthly, therefore the parents\u002Fcaregivers will received email-reminders. Appropriate feedback on their TRACK-scores will be provided by their healthcare team within two working days. Any interventions such as adjustment of treatment are at the judgment of the treating pediatrician. Therapy adherence will be monitored during the study by using smart inhalers.",[28,176,177],"Telemedicine","Wheezing","2024-06-07",{"date":180,"type":36},"2024-06-10",{"date":182,"type":20},"2024-08-01",{"date":184,"type":20},"2027-02-01",{"name":186,"class":43},"Radboud University Medical Center",{"id":188,"slug":189,"hasResults":11,"nctId":190,"briefTitle":191,"officialTitle":192,"acronym":193,"eligibilityCriteria":194,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":195,"targetDuration":4,"studyType":21,"phases":197,"briefSummary":198,"conditions":199,"keywords":203,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":208,"lastUpdatePostDateStruct":209,"startDateStruct":211,"completionDateStruct":213,"leadSponsor":215,"locationsCount":4},"100548673","mitigating-toxicity-by-electronic-health-portal-mediated-interactive-monitoring-of-patient-reported-side-effects-100548673","NCT06424054","Mitigating Toxicity by Electronic Health Portal-mediated Interactive Monitoring of Patient-reported Side Effects","Mitigating Toxicity of (Neo)Adjuvant Chemotherapy by Applying Electronic Health Portal-mediated Interactive Monitoring of Patient-reported Side Effects: the Prospective Randomized eChemoCoach Trial","eChemoCoach","Inclusion Criteria:\n\n* \\- Starting (neo)adjuvant treatment with chemotherapy for breast cancer according to one of the below mentioned treatment protocols:\n\n  * Four cycles of doxorubicin 60mg\u002Fm2 and cyclophosphamide 600mg\u002Fm2 (AC) dose dense q 2 weeks, followed by twelve cycles of weekly paclitaxel 80mg\u002Fm2 (also in combination with carboplatin AUC6 q 3 weeks)\n  * Nine cycles q 3 weeks of paclitaxel 80mg\u002Fm2 on day 1 and 8, carboplatin AUC 3 on day 1 and 8, trastuzumab 8mg\u002Fkg loading dose (followed by doses of 6mg\u002Fm2 at subsequent cycles) on day1 and pertuzumab loading dose of 840mg (followed by doses of 420mg at subsequent cycles) on day 1\n* Age ≥ 18 years\n* WHO PS ≤1\n* Capable of using the EHP or get help in case of low (e-)health literacy. This includes being capable of login using DigiD, a system used by the Dutch government to verify the identity of a person\n* Being able to read or get help from a relative in case of illiteracy\n\nExclusion Criteria:\n\n* \\- Participation in a trial with an investigational product (because more frequent and structured symptom reporting is performed in these studies).\n* Patients who have been treated with chemotherapy in the past (since these patients are at higher risk for developing side effects of current chemotherapy).\n* Patients that already started with their chemotherapy cycle",{"count":196,"type":20},746,[23],"Chemotherapy induces side effects varying in severity, impacting patients' quality of life and necessitating unplanned hospital care. Patient-reported outcomes (PROs) could aid in early detection and management of side effects. However, existing PRO monitoring lacks triage capabilities, leading to clinician involvement and suboptimal symptom management. The investigators propose eChemoCoach, an electronic questionnaire integrated into the electronic health portal, offering real-time symptom assessment and personalized advice based on CTCAE criteria. Our study aims to assess the impact of eChemoCoach on non-hematological CTCAE ≥ 3 graded side effects in early breast cancer patients undergoing chemotherapy. This is a randomized controlled trial involving 746 patients that will evaluate the eChemoCoach's efficacy compared to standard monitoring. Phase one will validate questionnaires and assess usability, while phase two focuses on the primary outcome. Te investigators anticipate reduced severe side effects, thereby enhancing patients' quality of life, reducing stress, and minimizing hospital visits.",[200,28,201,202],"Breast Cancer","Symptom Monitoring","Self Management",[200,204,205,28,206,207],"remote monitoring","emonitoring","symptom management","symptom monitoring","2024-05-16",{"date":210,"type":36},"2024-05-21",{"date":212,"type":20},"2025-06-01",{"date":214,"type":20},"2029-12-01",{"name":216,"class":43},"Noordwest Ziekenhuisgroep",{"id":218,"slug":219,"hasResults":11,"nctId":220,"briefTitle":221,"officialTitle":222,"acronym":223,"eligibilityCriteria":224,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":225,"enrollmentInfo":226,"targetDuration":4,"studyType":21,"phases":228,"briefSummary":229,"conditions":230,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":234,"lastUpdatePostDateStruct":235,"startDateStruct":237,"completionDateStruct":239,"leadSponsor":241,"locationsCount":4},"100537090","towards-telemonitoring-in-immune-mediated-inflammatory-diseases-implementation-of-a-mixed-attention-model-imidoc-100537090","NCT06273306","Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC)","Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model","IMIDOC","Inclusion Criteria:\n\n* Clinical diagnosis with Rheumatoid Arthritis or Spondylarthritis\n* Treatment with biologic or targeted disease modifying antirheumatic drugs.\n* Ability to use smartphone.\n\nExclusion Criteria:\n\n* only patients with conditions that hinder or prevent the use of a mobile application (blindness, mental retardation, dementia, digitalfilliteracy).","80 Years",{"count":227,"type":20},360,[23],"The main objective is to evaluate the implementation of a hybrid care model called the mixed attention model (MAM) in clinical practice and to evaluate whether its implementation improves clinical outcomes compared to conventional follow-up.\n\nThis is a multicenter prospective observational study involving 360 patients with rheumatoid arthritis (RA) and Spondylarthritis (SpA) from five Spanish Hospitals. Patients will be followed-up by the MAM protocol, which is a care model that incorporates the use of digital tool consisting of a mobile application (App) that patients can use at home and that professionals can review asynchronously to detect incidents and to follow their patients; clinical evolution between face-to-face visits. Another group of patients, whose follow-up will be conducted in accordance with a traditional face-to-face care model, will be assessed as the control group. Sociodemographic characteristics, treatments, laboratory parameters, assessment of tender and swollen joints, visual analogue scale for pain and electronic patient reported outcome reports (ePROs) will be collected for all subjects. In the MAM group, these items will be self-assessed both by the mobile App and during face-to-face visits with rheumatologist, who will do the same for patients included in the traditional care model. Patients will be able to report any incidence related to their disease or treatment through the mobile App.",[176,88,28,231,232,233],"Rheumatic Diseases","Arthritis, Rheumatoid","Spondylarthritis","2024-02-15",{"date":236,"type":36},"2024-02-22",{"date":238,"type":20},"2024-03-15",{"date":240,"type":20},"2026-12-31",{"name":242,"class":43},"Instituto de Investigación Hospital Universitario La Paz"]